Table 4.
The correlations of CXCR1 with clinicopathological features of patients with gastric cancer
| Characteristics | Patients(n) | CXCR1 expression |
P values | |
|---|---|---|---|---|
| Low expression (n = 20) | High expression (n = 28) | |||
| Age (years) | ||||
| ≤60 | 32 | 14 | 18 | 0.679 |
| >60 | 16 | 6 | 10 | |
| Tumor size (cm) | ||||
| ≤5 | 16 | 8 | 8 | 0.408 |
| >5 | 32 | 12 | 20 | |
| Gender | ||||
| Male | 31 | 13 | 18 | 0.959 |
| Female | 17 | 7 | 10 | |
| TNM stage | ||||
| I – II | 27 | 11 | 16 | 0.883 |
| III–IV | 21 | 9 | 12 | |
| Tumor differentiation | ||||
| Well + moderate | 29 | 14 | 15 | 0.251 |
| Poor | 19 | 6 | 13 | |
| Lymph node metastasis | ||||
| Absent | 28 | 12 | 16 | 0.843 |
| Present | 20 | 8 | 12 | |
| Distant metastasis | ||||
| Absent | 21 | 13 | 8 | 0.012* |
| Present | 27 | 7 | 20 | |
*P < 0.05 Statistically significant.